Singapore: Market for Medicaments Of Penicillins, Streptomycins Or Derivatives Thereof 2026
Market Size for Medicaments Of Penicillins, Streptomycins Or Derivatives Thereof in Singapore
The Singaporean penicillins or streptomycins medicaments market skyrocketed to $X in 2025, rising by X% against the previous year. Overall, consumption, however, showed a relatively flat trend pattern. As a result, consumption attained the peak level of $X. From 2023 to 2025, the growth of the market remained at a lower figure.
Production of Medicaments Of Penicillins, Streptomycins Or Derivatives Thereof in Singapore
In value terms, penicillins or streptomycins medicaments production surged to $X in 2025 estimated in export price. Overall, production, however, saw a perceptible setback. The most prominent rate of growth was recorded in 2017 when the production volume increased by X%. Over the period under review, production attained the maximum level at $X in 2021; however, from 2022 to 2025, production stood at a somewhat lower figure.
Exports of Medicaments Of Penicillins, Streptomycins Or Derivatives Thereof
Exports from Singapore
After two years of decline, shipments abroad of medicaments of penicillins, streptomycins or derivatives thereof increased by X% to X tons in 2025. Overall, exports enjoyed a mild increase. The pace of growth was the most pronounced in 2018 with an increase of X% against the previous year. The exports peaked at X tons in 2021; however, from 2022 to 2025, the exports remained at a lower figure.
In value terms, penicillins or streptomycins medicaments exports skyrocketed to $X in 2025. In general, exports, however, recorded a perceptible reduction. The most prominent rate of growth was recorded in 2018 when exports increased by X% against the previous year. Over the period under review, the exports hit record highs at $X in 2021; however, from 2022 to 2025, the exports remained at a lower figure.
Exports by Country
South Korea (X tons), Hong Kong SAR (X tons) and Myanmar (X tons) were the main destinations of penicillins or streptomycins medicaments exports from Singapore, together accounting for X% of total exports. Taiwan (Chinese), Malaysia, Australia, Japan, Zambia, Sri Lanka, Indonesia and Thailand lagged somewhat behind, together comprising a further X%.
From 2012 to 2025, the biggest increases were recorded for Taiwan (Chinese) (with a CAGR of X%), while shipments for the other leaders experienced more modest paces of growth.
In value terms, Hong Kong SAR ($X), South Korea ($X) and Taiwan (Chinese) ($X) were the largest markets for penicillins or streptomycins medicaments exported from Singapore worldwide, together comprising X% of total exports.
Among the main countries of destination, Taiwan (Chinese), with a CAGR of X%, saw the highest growth rate of the value of exports, over the period under review, while shipments for the other leaders experienced more modest paces of growth.
Export Prices by Country
The average penicillins or streptomycins medicaments export price stood at $X per ton in 2025, dropping by X% against the previous year. In general, the export price showed a noticeable curtailment. The pace of growth appeared the most rapid in 2022 when the average export price increased by X% against the previous year. As a result, the export price attained the peak level of $X per ton. From 2023 to 2025, the average export prices failed to regain momentum.
Prices varied noticeably by country of destination: amid the top suppliers, the country with the highest price was Australia ($X per ton), while the average price for exports to Myanmar ($X per ton) was amongst the lowest.
From 2012 to 2025, the most notable rate of growth in terms of prices was recorded for supplies to Australia (X%), while the prices for the other major destinations experienced a decline.
Imports of Medicaments Of Penicillins, Streptomycins Or Derivatives Thereof
Imports into Singapore
In 2025, the amount of medicaments of penicillins, streptomycins or derivatives thereof imported into Singapore soared to X tons, picking up by X% against the previous year's figure. Over the period under review, imports posted significant growth. The pace of growth appeared the most rapid in 2014 when imports increased by X%. Over the period under review, imports attained the peak figure at X tons in 2016; however, from 2017 to 2025, imports failed to regain momentum.
In value terms, penicillins or streptomycins medicaments imports rose notably to $X in 2025. In general, imports enjoyed significant growth. The pace of growth appeared the most rapid in 2014 when imports increased by X%. Imports peaked at $X in 2016; however, from 2017 to 2025, imports failed to regain momentum.
Imports by Country
In 2025, Austria (X tons) constituted the largest penicillins or streptomycins medicaments supplier to Singapore, accounting for a X% share of total imports. Moreover, penicillins or streptomycins medicaments imports from Austria exceeded the figures recorded by the second-largest supplier, China (X tons), threefold. The UK (X tons) ranked third in terms of total imports with a X% share.
From 2012 to 2025, the average annual rate of growth in terms of volume from Austria totaled X%. The remaining supplying countries recorded the following average annual rates of imports growth: China (X% per year) and the UK (X% per year).
In value terms, the largest penicillins or streptomycins medicaments suppliers to Singapore were Austria ($X), the UK ($X) and India ($X), with a combined X% share of total imports. France, China, Italy, Malaysia, Germany and Taiwan (Chinese) lagged somewhat behind, together accounting for a further X%.
France, with a CAGR of X%, recorded the highest growth rate of the value of imports, among the main suppliers over the period under review, while purchases for the other leaders experienced more modest paces of growth.
Import Prices by Country
In 2025, the average penicillins or streptomycins medicaments import price amounted to $X per ton, shrinking by X% against the previous year. In general, the import price continues to indicate a relatively flat trend pattern. The most prominent rate of growth was recorded in 2022 when the average import price increased by X%. As a result, import price reached the peak level of $X per ton. From 2023 to 2025, the average import prices remained at a somewhat lower figure.
Prices varied noticeably by country of origin: amid the top importers, the country with the highest price was Italy ($X per ton), while the price for China ($X per ton) was amongst the lowest.
From 2012 to 2025, the most notable rate of growth in terms of prices was attained by Italy (X%), while the prices for the other major suppliers experienced more modest paces of growth.
Frequently Asked Questions (FAQ) :
The countries with the highest volumes of consumption in 2024 were China, Turkey and the United States, with a combined 37% share of global consumption.
The countries with the highest volumes of production in 2024 were China, India and Turkey, together accounting for 47% of global production.
In value terms, the largest penicillins or streptomycins medicaments suppliers to Singapore were Austria, the UK and India, together accounting for 59% of total imports. France, China, Italy, Malaysia, Germany and Taiwan Chinese) lagged somewhat behind, together comprising a further 35%.
In value terms, the largest markets for penicillins or streptomycins medicaments exported from Singapore were Hong Kong SAR, South Korea and Taiwan Chinese), together accounting for 63% of total exports.
In 2024, the average penicillins or streptomycins medicaments export price amounted to $22,279 per ton, with a decrease of -33.1% against the previous year. In general, the export price showed a pronounced decline. The pace of growth appeared the most rapid in 2022 when the average export price increased by 634%. As a result, the export price reached the peak level of $264,705 per ton. From 2023 to 2024, the average export prices remained at a somewhat lower figure.
In 2024, the average penicillins or streptomycins medicaments import price amounted to $49,261 per ton, reducing by -26.1% against the previous year. Over the period under review, the import price showed a relatively flat trend pattern. The most prominent rate of growth was recorded in 2022 when the average import price increased by 43% against the previous year. As a result, import price reached the peak level of $73,494 per ton. From 2023 to 2024, the average import prices failed to regain momentum.
This report provides a comprehensive view of the penicillins or streptomycins medicaments industry in Singapore, tracking demand, supply, and trade flows across the national value chain. It explains how demand across key channels and end-use segments shapes consumption patterns, while also mapping the role of input availability, production efficiency, and regulatory standards on supply.
Beyond headline metrics, the study benchmarks prices, margins, and trade routes so you can see where value is created and how it moves between domestic suppliers and international partners. The analysis is designed to support strategic planning, market entry, portfolio prioritization, and risk management in the penicillins or streptomycins medicaments landscape in Singapore.
Domestic demand is shaped by both household and industrial usage, with trade flows linking local supply to imports and exports.
Pricing dynamics reflect unit values, freight costs, exchange rates, and regulatory shifts that affect sourcing decisions.
Supply depends on input availability and production efficiency, creating a distinct national cost curve.
Market concentration varies by segment, creating different competitive landscapes and entry barriers.
The 2035 outlook highlights where capacity investment and demand growth are most aligned within the country.
Report scope
The report combines market sizing with trade intelligence and price analytics for Singapore. It covers both historical performance and the forward outlook to 2035, allowing you to compare cycles, structural shifts, and policy impacts.
Market size and growth in value and volume terms
Consumption structure by end-use segments
Production capacity, output, and cost dynamics
Trade flows, exporters, importers, and balances
Price benchmarks, unit values, and margin signals
Competitive context and market entry conditions
Product coverage
Prodcom 21201160 - Medicaments of penicillins, streptomycins or derivatives thereof, in doses or p.r.s.
Country coverage
Singapore
Country profile and benchmarks
This report provides a consistent view of market size, trade balance, prices, and per-capita indicators for Singapore. The profile highlights demand structure and trade position, enabling benchmarking against regional and global peers.
Methodology
The analysis is built on a multi-source framework that combines official statistics, trade records, company disclosures, and expert validation. Data are standardized, reconciled, and cross-checked to ensure consistency across time series.
International trade data (exports, imports, and mirror statistics)
National production and consumption statistics
Company-level information from financial filings and public releases
Price series and unit value benchmarks
Analyst review, outlier checks, and time-series validation
All data are normalized to a common product definition and mapped to a consistent set of codes. This ensures that comparisons across time are aligned and actionable.
Forecasts to 2035
The forecast horizon extends to 2035 and is based on a structured model that links penicillins or streptomycins medicaments demand and supply to macroeconomic indicators, trade patterns, and sector-specific drivers. The model captures both cyclical and structural factors and reflects known policy and technology shifts in Singapore.
Historical baseline: 2012-2025
Forecast horizon: 2026-2035
Scenario-based sensitivity to income growth, substitution, and regulation
Capacity and investment outlook for major producing companies
Each projection is built from national historical patterns and the broader regional context, allowing the report to show where growth is concentrated and where risks are elevated.
Price analysis and trade dynamics
Prices are analyzed in detail, including export and import unit values, regional spreads, and changes in trade costs. The report highlights how seasonality, freight rates, exchange rates, and supply disruptions influence pricing and margins.
Price benchmarks by country and sub-region
Export and import unit value trends
Seasonality and calendar effects in trade flows
Price outlook to 2035 under baseline assumptions
Profiles of market participants
Key producers, exporters, and distributors are profiled with a focus on their operational scale, geographic footprint, product mix, and market positioning. This helps identify competitive pressure points, partnership opportunities, and routes to differentiation.
Business focus and production capabilities
Geographic reach and distribution networks
Cost structure and pricing strategy indicators
Compliance, certification, and sustainability context
How to use this report
Quantify domestic demand and identify the most attractive segments
Evaluate export opportunities and prioritize target destinations
Track price dynamics and protect margins
Benchmark performance against leading competitors
Build evidence-based forecasts for investment decisions
This report is designed for manufacturers, distributors, importers, wholesalers, investors, and advisors who need a clear, data-driven picture of penicillins or streptomycins medicaments dynamics in Singapore.
FAQ
What is included in the penicillins or streptomycins medicaments market in Singapore?
The market size aggregates consumption and trade data, presented in both value and volume terms.
How are the forecasts to 2035 built?
The projections combine historical trends with macroeconomic indicators, trade dynamics, and sector-specific drivers.
Does the report cover prices and margins?
Yes, it includes export and import unit values, regional spreads, and a pricing outlook to 2035.
Which benchmarks are included?
The report benchmarks market size, trade balance, prices, and per-capita indicators for Singapore.
Can this report support market entry decisions?
Yes, it highlights demand hotspots, trade routes, pricing trends, and competitive context.
1. INTRODUCTION
Making Data-Driven Decisions to Grow Your Business
Market Volume, In Physical Terms: Historical Data (2012–2025) and Forecast (2026–2035)
Market Value: Historical Data (2012–2025) and Forecast (2026–2035)
Per Capita Consumption: Historical Data (2012–2025) and Forecast (2026–2035)
Imports, In Physical Terms, By Country, 2012–2025
Imports, In Value Terms, By Country, 2012–2025
Import Prices, By Country, 2012–2025
Exports, In Physical Terms, By Country, 2012–2025
Exports, In Value Terms, By Country, 2012–2025
Export Prices, By Country, 2012–2025
LIST OF FIGURES
Market Volume, In Physical Terms: Historical Data (2012–2025) and Forecast (2026–2035)
Market Value: Historical Data (2012–2025) and Forecast (2026–2035)
Market Structure – Domestic Supply vs. Imports, in Physical Terms: Historical Data (2012–2025) and Forecast (2026–2035)
Market Structure – Domestic Supply vs. Imports, in Value Terms: Historical Data (2012–2025) and Forecast (2026–2035)
Trade Balance, In Physical Terms: Historical Data (2012–2025) and Forecast (2026–2035)
Trade Balance, In Value Terms: Historical Data (2012–2025) and Forecast (2026–2035)
Per Capita Consumption: Historical Data (2012–2025) and Forecast (2026–2035)
Market Volume Forecast to 2035
Market Value Forecast to 2035
Market Size and Growth, By Product
Average Per Capita Consumption, By Product
Exports and Growth, By Product
Export Prices and Growth, By Product
Production Volume and Growth
Exports and Growth
Export Prices and Growth
Market Size and Growth
Per Capita Consumption
Imports and Growth
Import Prices
Production, In Physical Terms: Historical Data (2012–2025) and Forecast (2026–2035)
Production, In Value Terms: Historical Data (2012–2025) and Forecast (2026–2035)
Imports, In Physical Terms: Historical Data (2012–2025) and Forecast (2026–2035)
Imports, In Value Terms: Historical Data (2012–2025) and Forecast (2026–2035)
Imports, In Physical Terms, By Country, 2025
Imports, In Physical Terms, By Country, 2012–2025
Imports, In Value Terms, By Country, 2012–2025
Import Prices, By Country, 2012–2025
Exports, In Physical Terms: Historical Data (2012–2025) and Forecast (2026–2035)
Exports, In Value Terms: Historical Data (2012–2025) and Forecast (2026–2035)
Exports, In Physical Terms, By Country, 2025
Exports, In Physical Terms, By Country, 2012–2025
Exports, In Value Terms, By Country, 2012–2025
Export Prices, By Country, 2012–2025
Oct 14, 2025
U.S. Delays Tariff on Singapore's Pharmaceutical Exports
The U.S. postpones a 100% tariff on Singapore's pharmaceutical exports, allowing companies to seek exemptions. This impacts S$4 billion in annual exports, a key part of Singapore's trade with the United States.